Olivia Newton-John Cancer Research Institute

Organization name
Olivia Newton-John Cancer Research Institute
Parent OrgUnit
City
Heidelberg, Victoria
Country
Australia


Results 421-440 of 755 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
4215-Jul-2019Bone morphogenetic protein signaling in breast cancer progression.Chi, Lap Hing; Burrows, Allan D; Anderson, Robin L 
4221-Jul-2019Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer.Cheung, Yee-Ming Melody ; Ramchand, Sabashini K ; Yeo, Belinda ; Grossmann, Mathis 
4231-Jul-2019TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axis.Mielke, Lisa A; Liao, Yang; Clemens, Ella Bridie; Firth, Matthew A; Duckworth, Brigette; Huang, Qiutong; Almeida, Francisca F; Chopin, Michael; Koay, Hui-Fern; Bell, Carolyn A; Hediyeh-Zadeh, Soroor; Park, Simone L; Raghu, Dinesh; Choi, Jarny; Putoczki, Tracy L; Hodgkin, Philip D; Franks, Ashley E; Mackay, Laura K; Godfrey, Dale I; Davis, Melissa J; Xue, Hai-Hui; Bryant, Vanessa L; Kedzierska, Katherine; Shi, Wei; Belz, Gabrielle T
424Jul-2019PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics.Eapen, Renu S ; Nzenza, Tatenda C ; Murphy, Declan G; Hofman, M S; Cooperberg, M; Lawrentschuk, Nathan
425Jul-2019PSMA-PET guided hook-wire localization of nodal metastases in prostate cancer: a targeted approach.Clarebrough, Emma; Duncan, Catriona; Christidis, Daniel; Lavoipierre, Alain; Lawrentschuk, Nathan
426Jul-2019A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy.Sathianathen, Niranjan J; Jarosek, Stephanie; Lawrentschuk, Nathan; Bolton, Damien M ; Konety, Badrinath R
427Jul-2019The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation.Goh, Su Kah ; Do, Hongdo; Testro, Adam G ; Pavlovic, Julie ; Vago, Angela ; Lokan, Julie ; Jones, Robert M ; Christophi, Christopher ; Dobrovic, Alexander ; Muralidharan, Vijayaragavan 
428Jul-2019Somatic hypermutation of the YAP oncogene in a human cutaneous melanoma.Zhang, Xiaomeng; Tang, Jian Zhong; Vergara, Ismael A; Zhang, Youfang; Szeto, Pacman; Yang, Lie; Mintoff, Christopher; Colebatch, Andrew; Mcintosh, Lachlan; Mitchell, Katrina A; Shaw, Evangeline; Rizos, Helen; Long, Georgina V; Hayward, Nicholas; McArthur, Grant A; Papenfuss, Anthony T; Harvey, Kieran F; Shackleton, Mark
429Jul-2019Fiducial markers: can the urologist do better?Duncan, Catriona; Joon, Daryl Lim; Lawrentschuk, Nathan; Jenkins, Trish ; Schneider, Michal; Khoo, Vincent; Chao, Michael ; Lawlor, Marita ; O'Meara, Rachel ; Berry, Colleen ; Viotto, Angela ; Brown, Kerryn ; Wada, Morikatsu ; Foroudi, Farshad ; Sengupta, Shomik 
430Jul-2019A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.Cursons, Joseph; Souza-Fonseca-Guimaraes, Fernando; Foroutan, Momeneh; Anderson, Ashley; Hollande, Frédéric; Hediyeh-Zadeh, Soroor; Behren, Andreas; Huntington, Nicholas D; Davis, Melissa J
4311-Jun-2019Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma.Lassman, Andrew B; Roberts-Rapp, Lisa A; Sokolova, Irina; Song, Minghao; Pestova, Ekaterina; Kular, Rupinder; Mullen, Carolyn; Zha, Zheng; Lu, Xin; Gomez, Erica; Bhathena, Anahita; Maag, David; Kumthekar, Priya; Gan, Hui K ; Scott, Andrew M ; Guseva, Maria; Holen, Kyle D; Ansell, Peter; van den Bent, Martin J
432Jun-2019Is there a role for proton pump inhibitor prophylaxis in haematology patients?Leitinger, Emma; Hui, Lisa ; Grigg, Andrew P 
433Jun-2019Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.Sathianathen, Niranjan J; Konety, Badrinath R; Alarid-Escudero, Fernando; Lawrentschuk, Nathan; Bolton, Damien M ; Kuntz, Karen M
434Jun-2019Men's health on the web: an analysis of current resources.Teh, Jiasian ; Wei, Joe; Chiang, Glen; Nzenza, Tatenda C ; Bolton, Damien M ; Lawrentschuk, Nathan
435Jun-2019The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.Dizdarevic, S; Tulchinsky, M; McCready, V R; Mihailovic, J; Vinjamuri, S; Buscombe, J R; Lee, Sze Ting ; Frangos, S; Sathekge, M; Siraj, Q; Choudhury, P; Bom, H; Franceschi, M; Ugrinska, A; Paez, D; Hussain, R; Mailman, J; Luster, M; Virgolini, I
43616-May-2019Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph Nodes.Young, Anna Rachel; Da Gama Duarte, Jessica; Coulson, Rhiannon; O'Brien, Megan; Deb, Siddhartha; Lopata, Alex; Behren, Andreas; Mathivanan, Suresh; Lim, Elgene; Meeusen, Els
4377-May-2019The Structural Biology of Bcl-xL.Lee, Erinna F; Fairlie, W Douglas
438May-2019Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease.Arulananda, Surein; Do, Hongdo; Rivalland, Gareth; Loh, Zoe ; Musafer, Ashan; Lau, Eddie ; Mitchell, Paul; Dobrovic, Alexander ; John, Thomas 
439May-2019Analysis of a practical surgical skills laboratory for nerve sparing radical prostatectomy.Clarebrough, Emma; Christidis, Daniel; Lindner, Uri; Fernandes, Kimberly; Fleshner, Neil; Lawrentschuk, Nathan
44026-Apr-2019Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia.van Zelm, Menno C; Pumar, Marsus; Shuttleworth, Peter ; Aui, Pei M; Smart, Joanne M; Grigg, Andrew P ; Bosco, Julian J